Warren Averett Asset Management LLC Invests $231,000 in Thermo Fisher Scientific Inc (NYSE:TMO) Stock

Warren Averett Asset Management LLC purchased a new position in Thermo Fisher Scientific Inc (NYSE:TMO) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,322 shares of the medical research company’s stock, valued at approximately $231,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Klingenstein Fields & Co. LLC boosted its holdings in Thermo Fisher Scientific by 0.3% in the second quarter. Klingenstein Fields & Co. LLC now owns 165,243 shares of the medical research company’s stock worth $28,830,000 after acquiring an additional 512 shares in the last quarter. American Research & Management Co. boosted its holdings in Thermo Fisher Scientific by 7.2% in the second quarter. American Research & Management Co. now owns 2,990 shares of the medical research company’s stock worth $522,000 after acquiring an additional 200 shares in the last quarter. Harbour Capital Advisors LLC boosted its holdings in Thermo Fisher Scientific by 18,197.5% in the second quarter. Harbour Capital Advisors LLC now owns 1,201,051 shares of the medical research company’s stock worth $6,884,000 after acquiring an additional 1,194,487 shares in the last quarter. IBM Retirement Fund boosted its holdings in Thermo Fisher Scientific by 117.7% in the second quarter. IBM Retirement Fund now owns 9,537 shares of the medical research company’s stock worth $1,860,000 after acquiring an additional 5,157 shares in the last quarter. Finally, Sumitomo Life Insurance Co. boosted its holdings in Thermo Fisher Scientific by 10.6% in the second quarter. Sumitomo Life Insurance Co. now owns 29,052 shares of the medical research company’s stock worth $5,069,000 after acquiring an additional 2,778 shares in the last quarter. 83.36% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “Warren Averett Asset Management LLC Invests $231,000 in Thermo Fisher Scientific Inc (NYSE:TMO) Stock” was originally reported by BBNS and is owned by of BBNS. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://baseballnewssource.com/markets/warren-averett-asset-management-llc-acquires-shares-of-1322-thermo-fisher-scientific-inc-tmo/1600811.html.

Thermo Fisher Scientific Inc (NYSE TMO) opened at 188.30 on Friday. The company’s 50-day moving average price is $181.07 and its 200 day moving average price is $171.15. Thermo Fisher Scientific Inc has a 12 month low of $139.07 and a 12 month high of $194.30. The stock has a market capitalization of $73.46 billion, a PE ratio of 32.80 and a beta of 1.05.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The company had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same period last year, the firm earned $2.03 EPS. The firm’s revenue for the quarter was up 10.2% on a year-over-year basis. On average, analysts forecast that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be given a dividend of $0.15 per share. The ex-dividend date is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.32%. Thermo Fisher Scientific’s payout ratio is 10.45%.

Several equities research analysts have weighed in on the company. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $212.00 price target for the company in a report on Thursday. Cowen and Company reissued an “outperform” rating and issued a $220.00 price target (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. Morgan Stanley reissued an “overweight” rating and issued a $220.00 price target on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. Argus reissued a “buy” rating on shares of Thermo Fisher Scientific in a report on Tuesday, August 22nd. They noted that the move was a valuation call. Finally, BidaskClub cut Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. One equities research analyst has rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Thermo Fisher Scientific currently has a consensus rating of “Buy” and an average target price of $194.33.

In other Thermo Fisher Scientific news, SVP Gregory J. Herrema sold 30,000 shares of the stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $176.02, for a total transaction of $5,280,600.00. Following the completion of the sale, the senior vice president now directly owns 67,016 shares of the company’s stock, valued at approximately $11,796,156.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Seth H. Hoogasian sold 4,140 shares of the stock in a transaction that occurred on Monday, August 28th. The stock was sold at an average price of $177.80, for a total value of $736,092.00. Following the sale, the vice president now directly owns 25,518 shares of the company’s stock, valued at $4,537,100.40. The disclosure for this sale can be found here. Insiders have sold a total of 52,738 shares of company stock valued at $9,302,112 over the last ninety days. 0.49% of the stock is owned by insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with our FREE daily email newsletter.

 


Latest News

Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22
Tigers Player Might Play All Nine Positions During Same Game
Tigers Player Might Play All Nine Positions During Same Game


Leave a Reply

 
© 2006-2017 BBNS.